PPT-Selected National HIV Prevention and Care Outcomes

Selected National HIV Prevention and Care Outcomes Used to gauge progress towards national HIV prevention and care goals and direct resources most effectively Monitors steps required from the time a person . Despite this signi64257cant progress the number of children becoming newly infected with HIV remains unacceptably high About 240 000 210 000280 000 children became infected with HIV in 2013 The risk of a mother living with HIV passing the virus to h A Winnable Battle. Centers for Disease Control and Prevention. Burden of HIV in the United States. . . 1.2 M . ~. 50K. 1.2 million people . living with HIV. Approximately . 50,000 new infections annually. Introduction. Access to HIV services as key component of HIV response among sex workers. Vital elements of HIV prevention and care continuum (HIV prevention, testing and treatment). Challenges to sex workers’ access to HIV related services in Europe. among . Health Centers Partnering with State Health . Departments (Partnerships for Care). Technical Assistance Presentation. http://. www.hrsa.gov/grants/apply/assistance/bphchiv . hivsupplement@hrsa.gov. Centers for Disease Control and Prevention. Burden of HIV in the United States. . . 1.2 M . ~. 50K. 1.2 million people . living with HIV. Approximately . 50,000 new infections annually. . Presented To: TLC Network /MAI members TA Call. Presented By: Jamila Ealey, MPH and . Melanie Gwynn, MPH. Date: June 9, 2014. Overview. Test, Link, and Care Network . ARTAS forms. ARTAS database. TLC Network Expectations. Diana L. Jordan, RN, MS. Director, Division of Disease Prevention. Virginia Department of Health. Disclosures. Presenter . has no financial interest to disclose..  . This continuing education activity is managed and accredited by Professional Education Services Group in cooperation with HSRA and LRG. PESG, HSRA, LRG and all accrediting organization do not support or endorse any product or service mentioned in this activity. . T. oolbox?. Objectives for Module 1. Our . Mission(s) . Today:. Discuss the difference between HIV prevention for HIV-negative people, HIV prevention for people living with HIV, and HIV testing. Discuss . Presenter:. INTRODUCTION. This project was supported through Federal funds from the Division of AIDS (DAIDS), National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services Grant # UM01 AI068614: “Leadership Group for a Global HIV Vaccine Clinical Trials (Office of HIV/AIDS Network . Dr . Nduku. . Kilonzo. CEO, National AIDS Control Council, . Kenya. NATIONAL . AIDS CONTROL . COUNCIL. I AM Team Kenya! Welcome to our Symposia. Ending the AIDS epidemic and Achieving Universal Health Coverage by 2030 in Africa. Clinical and immunologic pattern of PLHIV lost from HIV care before initiated Antiretroviral treatment within an HIV Program in Tanzania Aisa N Muya, MD, MPH Management and Development for Health ( MDH) HIV”. Caregiving . in the context of HIV/. AIDS. UN Women for CSW57. Baby Rivona. Indonesian Positive Women Network. (IPPI). International Community of Women living with HIV reps; Asia Pacific. President decree no 3/2010; gender mainstreaming program in NAC and all Provincial AIDS Commission. Geneva 2019. Dr Venkatraman Chandra-Mouli. DEFINITIONS . Human immunodeficiency virus (HIV): . A virus that targets the immune system & weakens the body’s defense system against infections. . Antiretroviral medicines (ARVs): . he comprehensive package consists of the 15interventions that are essential for eective HIV prevention and treatment in closed settings. While each of these interventions alone is useful in addre